Tate & Lyle

Tate & Lyle PLC is a multinational company headquartered in London, specializing in providing high-quality ingredients and solutions for the food, beverage, and other industries worldwide. The company operates through three main segments: Food & Beverage Solutions, Sucralose, and Primary Products. Its offerings include texturants, nutritive sweeteners like high fructose corn syrup and dextrose, health and wellness ingredients, and stabilizers. Additionally, Tate & Lyle supplies industrial starches for various applications, including paper and packaging, as well as acidulants and commodities for animal nutrition. Following the divestiture of its commodity ingredients business in 2022 and its previous exit from the sugar sector, the company has shifted its focus towards specialty ingredients such as sweeteners, starches, and soluble fiber. With a workforce of approximately 2,700 employees, Tate & Lyle operates in over 140 countries, generating a significant portion of its revenue from North America.

David Atkinson

Managing Partner

Heather Roxborough

Principal

Jeffrey Sands

Senior Vice President, Strategy and M&A

25 past transactions

Quantum Hi-Tech China Biological

Acquisition in 2022
Quantum Hi-Tech China Biological researches, develops, produces and sells fructooligosaccharides (FOS) products.

Sweet Green Fields

Acquisition in 2020
Sweet Green Fields is a prominent innovator in the development of stevia leaf extracts, focusing on natural sweeteners and food additives for the beverages, dairy, and snacks industries. Established in 1999, the company began with a comprehensive plant breeding program aimed at creating improved stevia varieties. This initiative has led to proprietary stevia leaf advancements that support its commitment to delivering exceptional taste through its "taste the extraordinary" program. By integrating food science with its stevia innovations, Sweet Green Fields offers a diverse portfolio of sugar-like tasting sweeteners that cater to various consumer needs and preferences. As of December 2020, Sweet Green Fields operates as a subsidiary of Tate & Lyle plc.

Chaodee Modified Starch

Acquisition in 2020
Chaodee Modified Starch is a prominent manufacturer of tapioca-based food starch located in Nakhon Ratchasima, Thailand. The company specializes in producing modified tapioca and cassava starch, both of which are gluten-free and made from non-genetically modified organisms (non-GMO). These starches serve as versatile food alternatives and are utilized across various applications, including sauces, instant and canned soups, dressings, yogurt, and pudding, among others. Chaodee Modified Starch is dedicated to providing high-quality ingredients that cater to the growing demand for healthier food options.

Changing Health

Seed Round in 2018
Changing Health Limited is a company based in Newcastle upon Tyne, United Kingdom, established in 2015. It specializes in a digital platform aimed at helping individuals, particularly those with type 2 diabetes, manage their health through personalized lifestyle modifications in nutrition and exercise. The platform provides users with a variety of resources, including online videos, articles, and interactive activities, designed to educate and empower them to make lasting changes. By integrating health coaching grounded in behavioral psychology with engaging digital content, Changing Health delivers effective support for chronic disease management. This innovative approach allows healthcare organizations to offer scalable and impactful assistance, optimizing their resources to enhance patient outcomes.

Prolupin

Venture Round in 2018
Prolupin GmbH, founded in 2010 and based in Grimmen, Germany, specializes in the development and production of vegetable-based food ingredients derived from lupine seeds. As a spin-off from the Fraunhofer Institute for Process Engineering and Packaging, Prolupin leverages advanced expertise in lupine fractionation and food technology to create a range of products, including lupine protein isolate, ice cream, and various herbal food ingredients. These offerings cater to diverse sectors within the food industry, such as bakery, meat, pasta, and health foods, providing consumers with cholesterol-free, lactose-free, vegan, and gluten-free options. Prolupin's innovative approach is supported by multiple patents from the Fraunhofer Institute, solidifying its competitive position in the vegetable protein market.

Evolve Biosystems

Series B in 2017
Evolve Biosystems, Inc. is a biotechnology company based in Davis, California, focused on developing and marketing probiotic-based biotherapeutics aimed at establishing, restoring, and maintaining a healthy human microbiome. The company specializes in addressing gut dysbiosis across the human life cycle, particularly in newborns during their first six months of life. Evolve Biosystems utilizes a platform that combines specific probiotic bacteria with prebiotic oligosaccharides to create effective delivery systems. Their products include consumer-directed solutions for home use as well as specialized formulations for neonatal intensive care units. In addition to human health, the company also applies its discovery platform to address similar microbiome issues in production animals. Evolve Biosystems was incorporated in 2011.

Nutriati

Series A in 2017
Nutriati, Inc. is a company that specializes in researching, developing, and producing plant-based food products, primarily focusing on gluten-free chickpea protein and chickpea flour. Established in 2013 and headquartered in Henrico, Virginia, Nutriati offers functional plant-based ingredients that meet the growing consumer demand for high-protein and non-allergenic foods. Its products are designed to provide a clean taste profile and the necessary functional performance for various applications, including bread, baked goods, pasta, sauces, snacks, and non-dairy plant-based meat. By supplying these ingredients, Nutriati supports food companies in creating innovative products that cater to health-conscious consumers.

Evolve Biosystems

Series A in 2015
Evolve Biosystems, Inc. is a biotechnology company based in Davis, California, focused on developing and marketing probiotic-based biotherapeutics aimed at establishing, restoring, and maintaining a healthy human microbiome. The company specializes in addressing gut dysbiosis across the human life cycle, particularly in newborns during their first six months of life. Evolve Biosystems utilizes a platform that combines specific probiotic bacteria with prebiotic oligosaccharides to create effective delivery systems. Their products include consumer-directed solutions for home use as well as specialized formulations for neonatal intensive care units. In addition to human health, the company also applies its discovery platform to address similar microbiome issues in production animals. Evolve Biosystems was incorporated in 2011.

Gemacom Tech Indústria e Comércio

Acquisition in 2014
Gemacom Tech Indústria e Comércio is a producer and supplier specializing in the development and manufacturing of stabilizing systems and ingredient blends for the food industry. The company offers a diverse range of products, including modified starches, aromas, colorants, fruit and jam preparations, toppings, sweet and savory fillings, thickeners, and stabilizers. Additionally, Gemacom Tech provides milk and whey protein concentrates, automatized powder mixtures, cheese pastes, and various condiments, catering to the needs of food manufacturers and processors. Through its extensive product offerings, the company aims to support the formulation and enhancement of food products in various market segments.

Winway Biotechnology Natong

Acquisition in 2014
Winway Biotechnology Natong Co. Ltd. manufactures and markets polydextrose specialty fiber. The company is based in Nantong, China.

Jiangsu Howbetter Food

Acquisition in 2013
Jiangsu Howbetter Food Co. Ltd. provides stabilizer systems and ingredient blends for the dairy and beverage industries.

Biovelop International

Acquisition in 2013
Biovelop International AB focuses on the development and production of oat beta glucan and other specialty ingredients derived from cereal grains. The company specializes in fractionating oats to create high-quality ingredients suitable for various applications, including food, beverages, nutritional supplements, cosmetics, and personal care products. Among its offerings are PromOat, a soluble fiber from oat bran that aids in lowering cholesterol, regulating blood sugar, and enhancing digestive health, and Avenacare, a liquid oat beta glucan designed for cosmetics and personal care to alleviate skin irritation and improve hair strength. Additionally, Biovelop provides prOATein, a non-dairy, non-GMO oat protein that serves as a protein-rich alternative for enhancing the nutritional value of products such as bars, baked goods, meal replacements, and sports nutrition items.

Allylix

Venture Round in 2012
Allylix, Inc. is an early-stage biotechnology company based in San Diego, California, with research and development laboratories in Lexington, Kentucky. Founded in 2002, the company specializes in developing terpene products and their derivatives for various markets, including flavor and fragrance, food ingredients, pharmaceuticals, agriculture, and biofuels. Notable among its offerings is nootkatone, a grapefruit flavor used in beverages such as fruit juices and citrus-flavored sodas. Additionally, Allylix works on sesquiterpenes that contribute to the aroma chemical segment of the flavor and fragrance industry, as well as production platforms for the pharmaceutical and nutraceutical sectors.

Allylix

Series C in 2010
Allylix, Inc. is an early-stage biotechnology company based in San Diego, California, with research and development laboratories in Lexington, Kentucky. Founded in 2002, the company specializes in developing terpene products and their derivatives for various markets, including flavor and fragrance, food ingredients, pharmaceuticals, agriculture, and biofuels. Notable among its offerings is nootkatone, a grapefruit flavor used in beverages such as fruit juices and citrus-flavored sodas. Additionally, Allylix works on sesquiterpenes that contribute to the aroma chemical segment of the flavor and fragrance industry, as well as production platforms for the pharmaceutical and nutraceutical sectors.

Aquapharm Biodiscovery

Series C in 2010
Aquapharm is an innovative drug discovery company focussed on developing new products founded on the chemical diversity of marine micro-organisms. Their core focus is the development of novel pharmaceutical compounds leading to the development of novel antibiotics, targeting both Gram negative and Gram positive infections. In addition, Aquapharm's development pipeline is also fed by an active discovery portfolio of anti-oxidants, anti-inflammatories and novel biocatalysts.

Allylix

Series C in 2010
Allylix, Inc. is an early-stage biotechnology company based in San Diego, California, with research and development laboratories in Lexington, Kentucky. Founded in 2002, the company specializes in developing terpene products and their derivatives for various markets, including flavor and fragrance, food ingredients, pharmaceuticals, agriculture, and biofuels. Notable among its offerings is nootkatone, a grapefruit flavor used in beverages such as fruit juices and citrus-flavored sodas. Additionally, Allylix works on sesquiterpenes that contribute to the aroma chemical segment of the flavor and fragrance industry, as well as production platforms for the pharmaceutical and nutraceutical sectors.

Fugeia

Venture Round in 2008
Fugeia NV specializes in developing ingredients and nutrition technologies, focusing on arabinoxylan-oligosaccharides (AXOS), which offer various health benefits associated with wholegrain wheat. These benefits include potential prevention of lifestyle diseases such as diabetes, obesity, cardiovascular conditions, and cancer. The company has innovated technologies for prebiotic bread and AXOS-enriched beer, enhancing the levels of these beneficial compounds in these products. Fugeia's offerings cater to a wide range of market segments, including dairy and non-dairy beverages, ready-to-eat cereals, cookies, biscuits, bread, and pastries, as well as dietary supplements and therapeutics. Founded in 2008, the company is based in Heverlee, Belgium.

Allylix

Venture Round in 2007
Allylix, Inc. is an early-stage biotechnology company based in San Diego, California, with research and development laboratories in Lexington, Kentucky. Founded in 2002, the company specializes in developing terpene products and their derivatives for various markets, including flavor and fragrance, food ingredients, pharmaceuticals, agriculture, and biofuels. Notable among its offerings is nootkatone, a grapefruit flavor used in beverages such as fruit juices and citrus-flavored sodas. Additionally, Allylix works on sesquiterpenes that contribute to the aroma chemical segment of the flavor and fragrance industry, as well as production platforms for the pharmaceutical and nutraceutical sectors.

Aquapharm Biodiscovery

Series B in 2007
Aquapharm is an innovative drug discovery company focussed on developing new products founded on the chemical diversity of marine micro-organisms. Their core focus is the development of novel pharmaceutical compounds leading to the development of novel antibiotics, targeting both Gram negative and Gram positive infections. In addition, Aquapharm's development pipeline is also fed by an active discovery portfolio of anti-oxidants, anti-inflammatories and novel biocatalysts.

G. C. Hahn

Acquisition in 2007
G. C. Hahn & Co. manufactures customized food stabilizer systems for the food industry. G. C. Hahn & Co. products are used in milk, delicatessen, ready meals, sauces and soups, bakery, meat products, beverages, filling aids, fish products, savory snacks, fruit products, food service, and ice cream applications.

Cesalpinia food SpA

Acquisition in 2005
Cesalpinia food SpA manufactues and supplies food additives for food, pharmaceutical, and pet food industries. Cesalpinia food SpA provides gums, thickeners, stabilizers, jellifying agents, blends, and natural flours.

Continental Custom Ingredients

Acquisition in 2005
CCI is a recognised leader in dairy stabilisers and emulsifier systems and works closely with customers to develop ingredient systems for the North American market. CCI also has expertise in beverage flavours and vitamin and mineral fortification.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.